Cortexyme Company
Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.
Technology:
Gene therapy
Industry:
Biotechnology, Health Care, Medical, Pharmaceutical
Headquarters:
South San Francisco, California, United States
Founded Date:
2012
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
13
Total Funding:
225000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership